Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Fagan, Kevin J ^a,b   Rogers, Geraint B ^c   Melino, Michelle ^a   Arthur, Dionne M ^a   Costello, Mary Ellen ^a   Morrison, Mark ^a   Powell, Elizabeth E ^a,b   Irvine, Katharine M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RNA 16S;

ADULT; ARTICLE; ASCITES; ASCITES FLUID; B LYMPHOCYTE; BACTERIAL INFECTION; BACTERIAL LOAD; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DNA DETERMINATION; FEMALE; GENE SEQUENCE; HEPATIC ENCEPHALOPATHY; HOSPITAL READMISSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOPHENOTYPING; INCIDENCE; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LYMPHOCYTE COUNT; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROBIAL COMMUNITY; MONOCYTE; MORTALITY; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PHENOTYPE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPPER GASTROINTESTINAL BLEEDING; CHEMISTRY; CYTOLOGY; FIBROSIS; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PROGNOSIS;

BACTERIA (MICROORGANISMS);

ASCITIC FLUID; DNA, BACTERIAL; FEMALE; FIBROSIS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; MACROPHAGES; MALE; MIDDLE AGED; PROGNOSIS; RNA, RIBOSOMAL, 16S;

EID: 84924975679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120642     Document Type: Article

References (37)

1. Fagan KJ, Zhao EY, Horsfall LU, Ruffin BJ, Kruger MS, McPhail SM, et al. The burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change? Intern Med J 2014.
2. Leber B, Spindelboeck W, Stadlbauer V. Infectious complications of acute and chronic liver disease. Seminars in respiratory and critical care medicine 2012; 33: 80-95. doi: 10.1055/s-0032-1301737 PMID: 22447263
3. Arvaniti V D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010; 139: 1246-1256, 1256 e1241-1245. doi: 10.1053/j.gastro.2010.06.019 PMID: 20558165
4. Rogers GB, Russell LE, Preston PG, Marsh P, Collins JE, Saunders J, et al. Characterisation of bacteria in ascites - reporting the potential of culture-independent, molecular analysis. Eur J Clin Microbiol Infect Dis 2010; 29: 533-541. doi: 10.1007/s10096-010-0891-5 PMID: 20238135
5. Leentjens J, Kox M, Koch RM, Preijers F, Joosten LA, van dHJG, et al. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. American journal of respiratory and critical care medicine 2012; 186: 838-845. doi: 10.1164/rccm.201204-0645OC PMID: 22822024
6. Lebrun L, Pelletier G, Briantais MJ, Galanaud P, Etienne JP. Impaired functions of normal peripheral polymorphonuclear leukocytes in cirrhotic ascitic fluid. J Hepatol 1992; 16: 98-101. PMID: 1484173
7. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, Burroughs A, et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008; 57: 252-257. PMID: 17895356
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383. PMID: 3558716
9. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41: 845-850. PMID: 9462221
10. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proceedings of the National Academy of Sciences of the United States of America 2011; 108 Suppl 1: 4516-4522. doi: 10.1073/pnas.1000080107 PMID: 20534432
11. Dowd SE, Sun Y, Wolcott RD, Domingo A, Carroll JA. Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonella-infected pigs. Foodborne Pathog Dis 2008; 5: 459-472. doi: 10.1089/fpd.2008.0107 PMID: 18713063
12. Rogers GB, Bruce KD, Martin ML, Burr LD, Serisier DJ. Long-term macrolide therapy alters respiratory microbiota composition in bronchiectasis - a randomised, double-blind, placebo-controlled trial. Lancet Respiratory Medicine 2014.
13. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7: 335-336. doi: 10.1038/nmeth.f.303 PMID: 20383131
14. Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, et al. Dual-functional capability of CD3 +CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity. Blood 2011; 118: 3301-3310. doi: 10.1182/blood-2011-02-336321 PMID: 21821703
15. Poli A, Michel T, Theresine M, Andres E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009; 126: 458-465. doi: 10.1111/j.1365-2567.2008.03027.x PMID: 19278419
16. Such J, Frances R, Munoz C, Zapater P, Casellas JA, Cifuentes A, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 2002; 36: 135-141. PMID: 12085357
17. Rogers GB, van der Gast CJ, Bruce KD, Marsh P, Collins JE, Sutton J, et al. Ascitic microbiota composition is correlated with clinical severity in cirrhosis with portal hypertension. PLoS One 2013; 8: e74884. doi: 10.1371/journal.pone.0074884 PMID: 24086392
18. Zapater P, Frances R, Gonzalez-Navajas JM, de la Hoz MA, Moreu R, Pascual S, et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 2008; 48: 1924-1931. doi: 10.1002/hep.22564 PMID: 19003911
19. Bellot P, Garcia-Pagan JC, Frances R, Abraldes JG, Navasa M, Perez-Mateo M, et al. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology 2010; 52: 2044-2052. doi: 10.1002/hep.23918 PMID: 20979050
20. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638. PMID: 15831718
21. Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014; 513: 59-64. doi: 10.1038/nature13568 PMID: 25079328
22. Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 2011; 54: 562-572. doi: 10.1002/hep.24423 PMID: 21574172
23. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghoner A, Vidacek D, Siewert E, et al. Patients with acute on chronic liver failure display " sepsis-like" immune paralysis. J Hepatol 2005; 42: 195-201. PMID: 15664244
24. Berry PA, Antoniades CG, Carey I, McPhail MJ, Hussain MJ, Davies ET, et al. Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Intensive care medicine 2011; 37: 453-460. doi: 10.1007/s00134-010-2099-7 PMID: 21161643
25. Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, et al. Reduced monocyte HLADR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 2006; 44: 34-43. PMID: 16799971
26. Wolk K, Docke WD, von Baehr V, Volk HD, Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000; 96: 218-223. PMID: 10891454
27. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nature medicine 1997; 3: 678-681. PMID: 9176497
28. Wolk K, Kunz S, Crompton NE, Volk HD, Sabat R. Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J Biol Chem 2003; 278: 18030-18036. PMID: 12637533
29. Balkhy HH, Heinzel FP. Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. J Immunol 1999; 162: 3633-3638. PMID: 10092824
30. Garcia-Gonzalez M, Boixeda D, Herrero D, Burgaleta C. Effect of granulocyte-macrophage colonystimulating factor on leukocyte function in cirrhosis. Gastroenterology 1993; 105: 527-531. PMID: 8335207
31. Philippart F, Fitting C, Cavaillon JM. Lung microenvironment contributes to the resistance of alveolar macrophages to develop tolerance to endotoxin∗. Crit Care Med 2012; 40: 2987-2996. doi: 10.1097/CCM.0b013e31825b8d57 PMID: 22878679
32. Lu M, Varley AW, Munford RS. Persistently active microbial molecules prolong innate immune tolerance in vivo. PLoS Pathog 2013; 9: e1003339. doi: 10.1371/journal.ppat.1003339 PMID: 23675296
33. Quigley EM, Monsour HP. The gut microbiota and the liver: implications for clinical practice. Expert Rev Gastroenterol Hepatol 2013; 7: 723-732. doi: 10.1586/17474124.2013.848167 PMID: 24134195
34. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008; 455: 804-807. doi: 10.1038/nature07250 PMID: 18724361
35. Cholongitas E, Papatheodoridis GV, Lahanas A, Xanthaki A, Kontou-Kastellanou C, Archimandritis AJ. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int 2005; 25: 57-61. PMID: 15698399
36. Arroyo V, Garcia-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol 2014; 61: 396-407. doi: 10.1016/j.jhep.2014.04.012 PMID: 24751830
37. O'Brien AJ, Fullerton JN, Massey KA, Auld G, Sewell G, James S, et al. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med 2014; 20: 518-523. doi: 10.1038/nm.3516 PMID: 24728410